title: Successful treatment of linear IgA disease with salazosulphapyridine and intravenous immunoglobulins.
authors: M
authors: M
authors: Goebeler
authors: C
authors: C
authors: Seitz
authors: C
authors: C
authors: Rose
authors: C
authors: C
authors: Sitaru
authors: R
authors: R
authors: Jeschke
authors: A
authors: A
authors: Marx
authors: E B
authors: EB
authors: Bröcker
authors: D
authors: D
authors: Zillikens
mesh_terms: D000293:Adolescent; D001327:Autoimmune Diseases / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D012872:Skin Diseases, Vesiculobullous / Q000628:therapy*; D012460:Sulfasalazine / Q000627:therapeutic use*
chemical_list: D005765:Gastrointestinal Agents; D007070:Immunoglobulin A; D016756:Immunoglobulins, Intravenous; D012460:Sulfasalazine